Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Rubric Capital Management LP SPRY ARS Pharmaceuticals, Inc. 13G/A 8.06% 6mo
Point72 Asset Management, L.P. CRVS Corvus Pharmaceuticals, Inc. 13G/A 0% 6mo
DISCIPLINED GROWTH INVESTORS INC /MN GEOS Geospace Technologies Corp 13G/A 8.5% 6mo
RIVERNORTH CAPITAL MANAGEMENT, LLC GLQ Clough Global Equity Fund 13G/A 6.55% 6mo
PERCEPTIVE ADVISORS LLC AMLX Amylyx Pharmaceuticals, Inc. 13G/A 7.5% 6mo
Sirenia Capital Management LP CCCC C4 Therapeutics, Inc. 13G 9.9% 6mo
METEORA CAPITAL, LLC GTEN Gores Holdings X, Inc. 13G/A 7.26% 6mo
Sirenia Capital Management LP OKYO OKYO Pharma Ltd 13G 7.7% 6mo
Nantahala Capital Management, LLC ABEO Abeona Therapeutics Inc. 13G/A 9.99% 6mo
Manulife Investment Management (US) LLC SBFG Sb Financial Group, Inc. 13G/A 7.47% 6mo
Anson Funds Management LP SVIA Silvia, Inc. 13G/A 0.5% 6mo
VIKING GLOBAL INVESTORS LP ORKA Oruka Therapeutics, Inc. 13G/A 5.3% 6mo
Shigeki Saitoh KDK Kodiak AI, Inc. 13G/A 6.9% 6mo
North Reef Capital Management LP MKTX Marketaxess Holdings Inc 13G 5.27% 6mo
Lineage Point Capital LP BEBE TGE Value Creative Solutions Corp 13G/A 7.31% 6mo
Point72 Asset Management, L.P. IOBTQ IO Biotech, Inc. 13G/A 0% 6mo
ARMISTICE CAPITAL, LLC EVGN Evogene Ltd. 13G 9.99% 6mo
RA CAPITAL MANAGEMENT, L.P. DNTH Dianthus Therapeutics, Inc. 13G/A 4.8% 6mo
ORBIMED ADVISORS LLC AVTX Avalo Therapeutics, Inc. 13G/A 2.1% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ RDNT RadNet, Inc. 13G 5.4% 6mo
Divisadero Street Capital Management, LP OMDA Omada Health, Inc. 13G 9.9% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ UEC Uranium Energy Corp 13G/A 15.5% 6mo
First Trust Capital Management L.P. RAAQ Real Asset Acquisition Corp. 13G/A 2.45% 6mo
Global X Management CO LLC DNN Denison Mines Corp. 13G/A 7.07% 6mo
Orbis Investment Management Limited FBIN Fortune Brands Innovations, Inc. 13G/A 0.6% 6mo
WELLINGTON MANAGEMENT GROUP LLP AMRC Ameresco, Inc. 13G/A 10.2% 6mo
T. Rowe Price Investment Management, Inc. UMH Umh Properties, Inc. 13G/A 4.3% 6mo
AMERIPRISE FINANCIAL INC BUR Burford Capital Ltd 13G/A 5.6% 6mo
ADAR1 Capital Management, LLC EQ Equillium, Inc. 13G/A 9.9% 6mo
T. Rowe Price Investment Management, Inc. KYMR Kymera Therapeutics, Inc. 13G 6.7% 6mo
Timothy G. Youngquist 2020 Irrevocable Trust CHRS Coherus Oncology, Inc. 13G/A 8.3% 6mo
Berkshire Hathaway Inc LILA Liberty Latin America Ltd. 13G/A 0% 6mo
GENDELL JEFFREY L NINE Nine Energy Service, Inc. 13G 5.6% 6mo
Fund 1 Investments, LLC GCO Genesco Inc 13G/A 3.92% 6mo
Manulife Investment Management (US) LLC LARK Landmark Bancorp Inc 13G/A 4.94% 6mo
WELLINGTON MANAGEMENT GROUP LLP ICLR Icon PLC 13G/A 7.7% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC BURU Nuburu, Inc. 13G 9.9% 6mo
EdgePoint Investment Group Inc. MAT Mattel Inc 13G/A 16.26% 6mo
Saba Capital Management, L.P. OIM OneIM Acquisition Corp. 13G/A 6.43% 6mo
ARMISTICE CAPITAL, LLC ARDS Aridis Pharmaceuticals Inc. Common Stock 13G/A 11.43% 6mo
Orbis Investment Management Limited PRAX Praxis Precision Medicines, Inc. 13G/A 8.9% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ LSCC Lattice Semiconductor Corp 13G/A 11.8% 6mo
Pentwater Capital Management LP GEO Geo Group Inc 13G 7.2% 6mo
Sirenia Capital Management LP OVID Ovid Therapeutics Inc. 13G 9.9% 6mo
EMINENCE CAPITAL, LP GTLB Gitlab Inc. 13G/A 0% 6mo
EAGLE CAPITAL MANAGEMENT LLC AER AerCap Holdings N.V. 13G/A 4.38% 6mo
HARRIS ASSOCIATES L P WEN Wendy's Co 13G/A 3.1% 6mo
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ GLIBA Liberty Capital Corp 13G/A 3.68% 6mo
Nantahala Capital Management, LLC PTON Peloton Interactive, Inc. 13G 7.31% 6mo
Bay Pond Partners, L.P. CUBI Customers Bancorp, Inc. 13G/A 5% 6mo